Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on a 5.5% revenue improvement. In ...
Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced Artificial Intelligence (AI) based design ...
Pritzker described the upcoming budget as “challenging” but added that since taking office, he’s addressed a number of fiscal crises in Illinois. “We are doing the best that we can to try ...
Vietnam Zoladex Market Key Takeaways: The Vietnam Zoladex market is witnessing notable growth driven by factors such as an increasing prevalence of hormone-related conditions, rising awareness about ...
To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering hundreds of diseases, drugs, and markets and 11 integrated data sets that span ...
Objective Juvenile SLE (jSLE) is an autoimmune disease characterised by the presence of high levels of autoantibodies, predominantly targeting nuclear antigens, resulting in a breakdown of ...